Table 1.
Natural ligands | Refs. | Synthetic ligands | Refs. | Tissue expression | Refs. | Physiological role | Refs. |
---|---|---|---|---|---|---|---|
Unsaturated Fatty Acids | [44] | Pioglitazone | [88] | High-Adipose tissue (white and brown) | [1], [155] | Glucose homoeostasis | [133], [42] |
Prostaglandin A1 | [8] | Rosiglitazone | [96] | Low-Intestines, Liver, Retina | [16] | Lipid storage | [155] |
15-deoxy-Δ12,14-PGJ2 | [180] | Troglitazone | [96] | Low-Heart | [16] | Differentiation and maturation of adipocytes | [155] |
Nitroalkenes | [140] | Ciglitazone | [122] | Low-Muscle | [162] | Fatty acid oxidation | [14], [15] |
Oxidized phospholipids | [39] | Glitazars | [2] | Low-Brain (oligodendrocytes, neurons, astrocytes, microglia) | [109], [61] | ||
PPARγ modulators | [177] | ||||||
Non-steroidal anti-inflammatory drugs | [95] |